Scientech Research LLC Buys New Stake in Crocs, Inc. (NASDAQ:CROX)

Scientech Research LLC purchased a new position in Crocs, Inc. (NASDAQ:CROX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,473 shares of the textile maker’s stock, valued at approximately $1,237,000.

Several other institutional investors have also bought and sold shares of CROX. Lighthouse Investment Partners LLC bought a new stake in Crocs during the second quarter worth approximately $243,000. Dark Forest Capital Management LP bought a new position in shares of Crocs during the 2nd quarter valued at approximately $410,000. Delta Investment Management LLC bought a new position in shares of Crocs during the 2nd quarter valued at approximately $206,000. AXA S.A. raised its holdings in Crocs by 5.9% during the 2nd quarter. AXA S.A. now owns 45,494 shares of the textile maker’s stock valued at $6,639,000 after buying an additional 2,536 shares during the period. Finally, Caxton Associates LP purchased a new position in Crocs during the second quarter worth $1,293,000. Institutional investors own 93.44% of the company’s stock.

Crocs Stock Down 2.1 %

Shares of Crocs stock opened at $144.31 on Friday. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.50 and a quick ratio of 0.95. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 11.17, a PEG ratio of 1.44 and a beta of 2.00. The firm’s 50-day moving average is $135.41 and its two-hundred day moving average is $138.43. Crocs, Inc. has a 1 year low of $74.00 and a 1 year high of $165.32.

Crocs (NASDAQ:CROX) last released its quarterly earnings data on Thursday, August 1st. The textile maker reported $4.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.59 by $0.42. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. Crocs had a net margin of 20.02% and a return on equity of 53.20%. The company’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period last year, the firm earned $3.59 earnings per share. As a group, research analysts expect that Crocs, Inc. will post 12.85 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CROX. Wedbush reissued an “outperform” rating and issued a $170.00 target price on shares of Crocs in a research note on Monday, July 29th. KeyCorp increased their price objective on shares of Crocs from $149.00 to $155.00 and gave the stock an “overweight” rating in a research report on Thursday. UBS Group dropped their target price on Crocs from $148.00 to $146.00 and set a “neutral” rating for the company in a research report on Tuesday, July 16th. StockNews.com upgraded Crocs from a “hold” rating to a “buy” rating in a report on Friday, August 23rd. Finally, Barclays dropped their price objective on Crocs from $169.00 to $164.00 and set an “overweight” rating for the company in a report on Friday, August 2nd. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, Crocs has an average rating of “Moderate Buy” and a consensus price target of $160.82.

Insider Activity at Crocs

In other news, Director Douglas J. Treff sold 10,594 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the sale, the director now owns 81,254 shares in the company, valued at $10,756,404.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Douglas J. Treff sold 10,594 shares of the stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $132.38, for a total value of $1,402,433.72. Following the transaction, the director now directly owns 81,254 shares of the company’s stock, valued at $10,756,404.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John B. Replogle purchased 1,996 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was acquired at an average price of $123.96 per share, for a total transaction of $247,424.16. Following the acquisition, the director now owns 7,064 shares in the company, valued at approximately $875,653.44. The disclosure for this purchase can be found here. 2.72% of the stock is currently owned by corporate insiders.

Crocs Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.